Escalation - if an extension had not been agreed and the report is not received
by the 50/60 working day deadline – the investigator will contact the reviewer to
ascertain an expected date of delivery. The Assistant Ombudsman will inform
the Commissioning Officer that the review is now overdue.
Escalation - if the report is not received by the extended date (in either case) –
the Assistant Ombudsman will contact the reviewer reminding them of the agreed
timescales and extensions. The Assistant Ombudsman will also write to the
Commissioning Officer informing them of the late review.
In each case, when a review is received outside of the agreed timescales, the
Deputy Ombudsman will inform the National Commissioning Board.
Clinical review template – Foreseeable Death
6. STAGES FOLLOWING THE PPO INVESTIGATION AND CLINICAL
REVIEW
There are a number of stages following the investigation and clinical review that
the reviewer should be aware of, as follows:
-
The PPO investigator writes a draft report including the clinical issues and
relevant recommendations.
-
The draft report is issued to the family (who have up to 8 weeks to feed
back) and the service (who have 4 weeks to feed back). Copies will be
sent to the NHS Area team and clinical reviewer for factual accuracy
checking.
-
The service and healthcare provider are asked to provide an action plan
in response to any recommendations.
-
More questions may be asked, and occasionally it may be necessary
for further investigation to take place, which may include clinical
matters.
-
The report is finalised, including the response to any recommendations,
and is used by the Coroner to prepare for the inquest.
-
Inquest - both the PPO investigator and clinical reviewer may be called to
give evidence at the inquest.
-
After the inquest, the annexes (including the clinical review report) are
removed from the PPO report – the report is anonymised and published
on the PPO website.
NOTE: At the consultation stage (b) advanced disclosure is provided if an
individual member of staff is criticised.
If the final report (e) goes on to make
serious criticisms of a member of staff, it will recommend that the appropriate
disciplinary procedures are implemented, and may in extreme cases, recommend
referral to the appropriate regulatory body. The Area Team (or equivalent)
should undertake such a referral.
Inquests
Both the PPO investigator and the clinical reviewer may be called to give
evidence at inquest. Although the inquest should not be an adversarial process,
the interested parties (which include the bereaved family and specific members of
staff from the service concerned) may have different perspectives of the
individual’s care and management than that identified by the PPO investigation
and/or clinical review. Each interested party may have their own legal
representation and each may require the PPO investigator and the clinical
reviewer to give evidence.
Clinical review template – Foreseeable Death
ANNEX A – Foreseeable deaths template
Clinical Review
for
[Name]
[Date of death]
[Establishment]
Carried out by [name of reviewer]
Date of final clinical review report: [date]
Clinical review template – Foreseeable Death
1. Terms of Reference
The aim of the review is to consider the clinical care the deceased received in
relation to his/her cause of death while in prison custody.
The approach of how and why should be adopted, not who was to blame.
The following key questions should be covered in relation to the death:
- How and when did the prisoner die?
- Is there any root cause(s) of the death?
- Was the clinical care equal to that which could have been expected
in the community?
- Are there any learning opportunities?
- Were local and national policies and procedures (both prison and
NHS) followed?
- Is there an opportunity to prevent future deaths in similar
circumstances?
- Are there any examples of good practice?
The review should:
- Examine the provision of clinical care and treatment, including both
risk assessment and risk management.
- Examine any secondary care provided (to the extent necessary for
the review)
- Provide a chronology of the health and social care events leading
up to the incident.
- Identify any care or service delivery failings along with the factors
that contributed to these problems.
- Examine policy and practice.
- Identify any root causes(s) that inform the identification of learning
opportunities.
- Make timely, clear and sustainable recommendations for the prison
health care provider and service.
- Provide explanations and insight for the relatives of the deceased.
2. Methodology
This is a Level 1 review - healthcare and other relevant records have been
reviewed and the report written based on documentary evidence and
discussion with the PPO investigator.
The following Prison Service Orders and Information (PSO or PSI) should be
considered when appropriate:
PSI 03/2013 – Emergency response
PSI 64/2011 – Safer custody
PSO 3050 – Continuity of healthcare
Clinical review template – Foreseeable Death
Appendix A – chronology of events leading up to and post diagnosis. Include
dates, times and names of staff.
3. Clinical Reviewer
Details of the clinical reviewer, qualifications, area(s) of specialism etc.
4. Conflict of interest statement
The clinical reviewer is required to confirm there are no actual or potential
conflicts of interest. This has be to declared this in this paragraph of the
report.
Examples of conflicts of interest include:
Having a financial interest (e.g. holding shares, options or
partnership agreements) in the healthcare provider of this clinical
review
Having a financial or any other personal interest in the healthcare
provider of this clinical review
If you are employed by, or providing services to, the healthcare
provider/establishment of this clinical review
Receiving any kind of monetary or non-monetary payment or
incentive (including hospitality or commercial sponsorship) from
the healthcare provider of this clinical review
Canvassing, or negotiating with, any person with a view to entering
into any of the arrangements outlined above;
Having a close family member (which includes unmarried partners)
who fall into any of the categories outlined above; and
Having any other close relationship (current or historical) with the
healthcare provider/establishment
The above is a non-exhaustive list of examples, and it is the clinical reviewers
responsibility to ensure that any and all potential conflicts – whether or not of
the type listed above – are disclosed in writing to the commissioners of the
review.
5. The diagnosis of [prisoners name] terminal illness and informing him
of his condition
This section should contain anything relevant up to and including the
diagnosis.
Please include whether referrals were made appropriately and in line with
NHS/NICE guidelines (eg: two week referral for suspected cancer)
Clinical review template – Foreseeable Death
The clinical reviewer should conclude whether referrals and diagnosis was
timely, and the prisoner was appropriately informed.
(Examples of issues to include in this section):
Was a referral to specialist secondary health service made at onset of
symptoms?
If cancer suspected, was the referral made within the two week rule?
Was the appropriate information recorded in the medical record?
Was the prisoner given full information on the reason for the referral?
Following a diagnosis of terminal illness, was the patient informed in a timely
manner?
Were they offered sufficient support?
Were they kept informed about ongoing appointments, treatments and
prognosis?
6. [Prisoner’s name] clinical care
This section should contain all relevant clinical input relating to medical
treatment and nursing care after diagnosis. This should include palliative and
end of life care eg: pain and symptom control, holistic assessment, advance
care planning (including the appropriateness of DNACPR), with reference to
appropriate NHS/NICE guidelines.
The clinical reviewer should conclude whether medical treatment was
appropriate and comment on any delays in receiving treatment.
(Examples of issues to include in this section):
Was the deceased able to attend hospital appointments etc without difficulty?
On return to prison following appointments and treatments, were appropriate
clinical and nursing checks carried out?
Was there good communication between outside providers and prison
healthcare?
Was appropriate pain relief given at the appropriate times?
Were decisions about whether medication is held in possession or not
recorded in the file?
Were any security related decisions, e.g. the use of a syringe driver noted in
the file?
Were appropriate comfort aids supplied e.g. mattresses, chairs, modified cell?
Were palliative care agencies contacted?
Were treatment care plans in place and agreed with the prisoner?
7. [Prisoner’s name] location
From a clinical perspective only, whether the location of the prisoner was
appropriate and did not impede clinical care.
(Examples of issues to include in this section):
Was the prisoner able to stay in their cell until their condition dictated
otherwise?
Was the prison disability officer informed and an assessment of need carried
out if appropriate?
Clinical review template – Foreseeable Death
Was the prison equipped to care for prisoners with terminal illnesses or was
transfer to such a prison considered/facilitated?
Was consideration given to transfer the prisoner to a hospice or to hospital
inpatients, taking into account security issues and accessibility to the family?
8. Restraints, security and escorts – healthcare input into risk
assessments
The Graham Judgement, High Court 2007 – made it clear that there should
be appropriate healthcare input into risk assessments for the use of restraints.
Healthcare should not merely state ‘no objection to the use of restraints’ they
should give a clear account of the prisoner’s condition and how this impacts
on their risk of escape.
Clinical reviewers should comment on this aspect of the risk assessments
only.
9. Compassionate release – healthcare input into application process
Prisoners can be released from custody before their sentence has expired on
compassionate grounds for medical reasons. This is usually when they are
suffering from a terminal illness and have a life expectancy of less than three
months.
Clinical reviewers should comment on the healthcare input into
compassionate release applications, particularly in relation to life expectancy.
10. Conclusion
Clinical reviewers overall conclusion about the clinical care the prisoner
received including whether it was equivalent to that they could have expected
in the community
11. Recommendations
Clear recommendations to relevant parties (head of healthcare or
commissioners). Recommendations should be specific, short and to the point
and relate to the clinical care in respect of the terminal condition.
Other findings to bring to the attention of the NHS Area Team
(healthcare commissioners)
Anything uncovered by the clinical reviewer in relation to the healthcare
provider at the establishment – that may not necessarily relate to the care of
the prisoner concerned, or to the treatment of their terminal illness.
Other recommendations
That relate to the above paragraph
Annex A – Chronology of relevant events
Date
Time
Event
Location
Name
Source (eg IMR)
Clinical review template – Non-foreseeable Death
ANNEX B – other deaths (non-foreseeable) template
Clinical Review
for
[Name]
[Date of death]
[Establishment]
Carried out by [name of reviewer]
Date of final clinical review report: [date]
Clinical review template – Non-foreseeable Death
1. Terms of Reference
The aim of the review is to consider the clinical care the deceased received in
relation to his/her cause of death while in prison custody.
The approach of how and why should be adopted, not who was to blame.
The following key questions should be covered in relation to the death:
- How and when did the prisoner die?
- Is there any root cause(s) of the death?
- Was the clinical care equal to that which could have been expected
in the community?
- Are there any learning opportunities?
- Were local and national policies and procedures (both prison and
NHS) followed?
- Is there an opportunity to prevent future deaths in similar
circumstances?
- Are there any examples of good practice?
The review should:
- Examine the provision of clinical care and treatment, including both
risk assessment and risk management.
- Examine any secondary care provided (to the extent necessary for
the review)
- Provide a chronology of the health and social care events leading
up to the incident.
- Identify any care or service delivery failings along with the factors
that contributed to these problems.
- Examine policy and practice.
- Identify any root causes(s) that inform the identification of learning
opportunities.
- Make timely, clear and sustainable recommendations for the prison
health care provider and service.
- Provide explanations and insight for the relatives of the deceased.
2. Methodology
This is a [Level 2 or 3 review – delete as appropriate]
Level 2 – Single clinical reviewer - Review of records, interviews with
healthcare staff at the establishment carried out jointly with the PPO
investigator and report
Level 3 – Panel review with lead reviewer – Review of records, interviews
with healthcare staff and others as appropriate carried out jointly with the PPO
investigator.
The following Prison Service Orders and Information (PSO or PSI) should be
considered when appropriate:
Clinical review template – Non-foreseeable Death
PSI 03/2013 – Emergency response
PSI 64/2011 – Safer custody
PSO 3050 – Continuity of healthcare
PSO 45/2010 – IDTS
PSO 1700 – Segregation
PSO 1600 – Use of Force
PSI 74/2011 – Early days in custody
Appendix A – chronology of clinical events leading up to death. Include
dates, times and full names of staff.
3. Clinical Reviewer
Details of the clinical reviewer, qualifications, area(s) of specialism etc.
4. Conflict of interest statement
The clinical reviewer is required to confirm there are no actual or potential
conflicts of interest. This has be to declared this in this paragraph of the
report.
Examples of conflicts of interest include:
Having a financial interest (e.g. holding shares, options or
partnership agreements) in the healthcare provider of this clinical
review
Having a financial or any other personal interest in the healthcare
provider of this clinical review
If you are employed by, or providing services to, the healthcare
provider/establishment of this clinical review
Receiving any kind of monetary or non-monetary payment or
incentive (including hospitality or commercial sponsorship) from
the healthcare provider of this clinical review
Canvassing, or negotiating with, any person with a view to entering
into any of the arrangements outlined above;
Having a close family member (which includes unmarried partners)
who fall into any of the categories outlined above; and
Having any other close relationship (current or historical) with the
healthcare provider/establishment
The above is a non-exhaustive list of examples, and it is the clinical reviewers
responsibility to ensure that any and all potential conflicts – whether or not of
the type listed above – are disclosed in writing to the commissioners of the
review.
Dostları ilə paylaş: |